NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE MKT:ELMD) today announced that a new study published in Respiratory Therapy: The Journal of Pulmonary Technique shows that consistent use of ...
Roth analyst Kyle Bauser reiterated his “Buy” rating and raised his 12-month price target to $38.00 from $36.00 ...
Electromed, Inc. (ELMD) reported strong Q4 and FY'22 sales and is still growing its SmartVest segment. The stock has rebounded from lows and broke resistance levels, adding to the potential for a turn ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) today announced entry into agreement with two Home Medical Equipment (“HME”) distributors – one national and one regional – ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (NYSE American: ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution ...
Electromed develops and markets medical devices in the respiratory care field. Its main product is the SmartVest System, which delivers High Frequency Chest Wall Oscillation (HFCWO) therapy to help ...
Lenovo has said artificial intelligence will be a connective tissue for its products and highlighted concept products that include a digital assistant, connected health devices, and augmented and ...
Greetings, and welcome to Electromed's Fourth Quarter Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results